Retinal Imaging Linked to Diabetic Retinopathy Risk
Researchers identified new eye-scan indicators that could signal the onset of early diabetic eye damage.
Updated on Sept. 22, 2026 in Diabetes
Live Poll
Do you trust new diagnostic imaging technologies to improve your long-term health monitoring?
A study published August 20, 2026, found that specific markers in retinal scans are associated with early diabetic retinopathy in adults with diabetes. These findings provide potential new diagnostic insights for monitoring eye health in individuals with the condition.
Why it matters
Identifying these biomarkers could improve the ability to detect retinal changes before they progress to more severe stages of diabetic eye disease. This research underscores the importance of ongoing ocular surveillance for adults managing diabetes.
This cross-sectional study of 108 adults with a mean age of 58.3 years used macular optical coherence tomography angiography to assess retinal biomarkers. Researchers found that lower central vessel and perfusion density were independently associated with at least mild nonproliferative diabetic retinopathy.
The players
Ophthalmic Epidemiology
A peer-reviewed journal focused on the distribution and determinants of eye diseases and vision impairment.
The details
Researchers utilized 6x6-mm macular optical coherence tomography angiography (OCTA) to map the vascular structures within the eye. By quantifying the density of blood vessels and the perfusion of those vessels, the team established a correlation between reduced blood flow patterns and early-stage diabetic retinopathy. Severity was graded using the Early Treatment Diabetic Retinopathy Study scale, which confirmed that these vascular changes tracked with disease progression.
Timeline
Participants underwent macular imaging between February 2024 and July 2025.
The findings were published on August 20, 2026.
Health Landscape
This research builds upon the diagnostic framework established by the Early Treatment Diabetic Retinopathy Study, moving beyond traditional clinical grading. It represents a shift toward using high-resolution vascular imaging to detect subclinical changes in patients with diabetes.
If you are managing diabetes, it is worth discussing with your ophthalmologist whether advanced imaging options like OCTA are appropriate for your regular eye exams. These findings emphasize that long-term duration of diabetes remains a key risk factor for retinal changes.
The takeaway
Advanced retinal scans may offer a more precise way to monitor early-stage vascular damage in patients with diabetes. Continue to prioritize your annual dilated eye exams and maintain a conversation with your care team about your HbA1c levels, which remain a primary metric for systemic risk.
Further reading
For more information on managing your ocular health with diabetes, visit our Diabetes section.
Live Poll
Do you trust new diagnostic imaging technologies to improve your long-term health monitoring?
